Latka logo
Ncardia logo

Ncardiarevenue & acquisition

United States

Ncardia was acquired.

Ncardia is a biotechnology company specializing in the development and manufacture of induced pluripotent stem cell (iPSC)-derived cell models and assays for drug discovery, safety, and efficacy testing.

ncardia.comLinkedInUpdated Oct 5, 2026
Annual revenue
$8M
Dec 2023EST
Owner
Undisclosed
Date not on record
Employees
46
Dec 2023EST

Ncardia revenue

Ncardia has not published its revenue. Growjo puts it at about $8M a year (December 2023).

$0
$2.5M
$5M
$7.5M
$8M
2023
ReportedEstimateEvery reading has its own bar
As ofRevenueSource
Dec 2023$8MESTGrowjo estimate

Who owns Ncardia

Another company owns Ncardia. The date and price of the deal are not on record.

Ncardia CEO, founders & employees

Herman Spolders founded Ncardia and led it as CEO. Ncardia had 46 employees (December 2023, Growjo estimate).

0
20
40
46
2023
ReportedEstimateOne figure per year; a reported figure wins over an estimate

Ncardia FAQ

What was Ncardia's revenue?

Growjo estimates Ncardia's revenue at about $8M a year (December 2023). The company hasn't published its own figure.

How many employees does Ncardia have?

Growjo estimates Ncardia's headcount at about 46 (December 2023).

Who founded Ncardia?

Herman Spolders founded Ncardia.

Categories

How this page is sourced

2 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 5, 2026Data disclaimerReport a correctionClaim this profileRun Ncardia? Join the podcast